Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
13.21
-0.09 (-0.68%)
Dec 20, 2024, 4:00 PM EST - Market closed

Pliant Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-201.68-161.34-123.32-97.26-41.53-0.63
Upgrade
Depreciation & Amortization
2.131.841.821.541.311.11
Upgrade
Loss (Gain) From Sale of Investments
7.17-4.99-1.811.26--
Upgrade
Stock-Based Compensation
38.3644.4822.610.443.91.83
Upgrade
Other Operating Activities
3.22.391.861.670.27-
Upgrade
Change in Accounts Receivable
-1.980.027.28-2.23-7.05
Upgrade
Change in Accounts Payable
3.532.97-1.350.890.92-1.26
Upgrade
Change in Other Net Operating Assets
14.35-3.75.55-1.26-0.153.08
Upgrade
Operating Cash Flow
-132.94-116.36-94.63-75.44-37.27-2.75
Upgrade
Capital Expenditures
-3.7-0.92-1.76-1.95-1.53-0.96
Upgrade
Investment in Securities
136.83-126.09-148.4475.65-209.33-16.97
Upgrade
Investing Cash Flow
133.13-127.01-150.273.7-210.87-17.93
Upgrade
Long-Term Debt Issued
--10---
Upgrade
Net Debt Issued (Repaid)
19.91-10---
Upgrade
Issuance of Common Stock
3.34275.25217.562.98161.190.17
Upgrade
Other Financing Activities
-0.01-0.85-0.71-0.46--2.58
Upgrade
Financing Cash Flow
23.23274.41226.852.53213.2145.54
Upgrade
Net Cash Flow
23.4231.03-17.980.78-34.9324.86
Upgrade
Free Cash Flow
-136.64-117.28-96.39-77.4-38.8-3.71
Upgrade
Free Cash Flow Margin
--7422.91%-995.26%-1022.13%-92.79%-6.51%
Upgrade
Free Cash Flow Per Share
-2.27-2.00-2.29-2.16-1.82-2.29
Upgrade
Cash Interest Paid
2.141.150.62---
Upgrade
Levered Free Cash Flow
-84.08-66.86-51.12-42.56-23.66-4.05
Upgrade
Unlevered Free Cash Flow
-82.51-66.07-50.62-42.56-23.66-4.05
Upgrade
Change in Net Working Capital
-19.5-3.62-6.22-8.381.315.26
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.